Ctrl

K

Laronidase

Class
Lysosomal modulators
Subclass
Enzyme replacement therapy
Substance name
Laronidase
Brand names
Aldurazyme®
Common formulations
Concentrate for injectable solution
Dosage and administration
Adults patients
Treatment of mucopolysaccharidosis type 1Moderate-to-severe
0.58 mg/kg IV weekly
Indications for use
Labeled indications
Adults
Treatment of mucopolysaccharidosis type 1 (moderate-to-severe)
Pregnancy and breastfeeding
Pregnancy
All trimesters • Australia Category: B2
Use only if clearly needed.
Breastfeeding
Acceptable for use during breastfeeding.
Use with caution during breastfeeding.
Unknown amount excreted in breastmilk.
Unknown drug levels in breastfed infants.
Unlikely to cause adverse effects in breastfed infants.
Interactions
Drug(s)
Check Interactions
Reset

What did you think about this content?

Sign up for free to access the full drug resource